DOI: 10.52341/20738080_2025_139_6_53 ISSN: 2073-8080
THERAPY OF THE CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND EXPRESSION LEVEL OF THE BIOMARKERS OF FIBROSIS AND REMODELING IN THE PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES
O. BELAYa, V. ORANZhEREEVA, E. KOVALENKO, I. RYZhKOV, E. LOBANOVAThe article assesses dynamics of the concentration of biomarkers of fibrosis and remodeling in the patients with stable coronary heart disease combined with chronic heart failure I–III functional class according to the NYHA classification, chronic kidney disease and type 2 diabetes against the background of therapy conducted during a year.